Durbin
Advice on the new European GDP guidance
September 03 by Pharmaceuticals & Biotechnology EditorHow will the new GDP guidance affect the clinical supply chain? In particular how will it affect the non IMP supply chain? These guidelines outlined significant changes within the areas of...
Comparator Sourcing in a Global World
April 19 by Robert DonnellWith globalisation complicating the delivery of clinical trials, having a truly international sourcing company has become essential. Robert Donnell, head of business development at Durbin, talks a...